SE436645C - Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar - Google Patents

Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar

Info

Publication number
SE436645C
SE436645C SE7604972A SE7604972A SE436645C SE 436645 C SE436645 C SE 436645C SE 7604972 A SE7604972 A SE 7604972A SE 7604972 A SE7604972 A SE 7604972A SE 436645 C SE436645 C SE 436645C
Authority
SE
Sweden
Prior art keywords
antibodies
production
active polypeptide
cancer diagnosis
antigenically active
Prior art date
Application number
SE7604972A
Other languages
English (en)
Other versions
SE7604972L (sv
SE436645B (sv
Inventor
Luening Bjoern Erik Bertilsson
Original Assignee
Bonnierfoeretagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnierfoeretagen Ab filed Critical Bonnierfoeretagen Ab
Priority to SE7604972A priority Critical patent/SE436645C/sv
Priority to DE19772717741 priority patent/DE2717741A1/de
Priority to US05/789,665 priority patent/US4107298A/en
Priority to GB17167/77A priority patent/GB1570375A/en
Priority to JP4977077A priority patent/JPS52156819A/ja
Priority to CA277,237A priority patent/CA1106360A/en
Priority to MX775685U priority patent/MX4699E/es
Priority to DD7700198643A priority patent/DD130476A5/xx
Priority to BR7702737A priority patent/BR7702737A/pt
Priority to FR7713001A priority patent/FR2349569A1/fr
Priority to CH539877A priority patent/CH630060A5/de
Publication of SE7604972L publication Critical patent/SE7604972L/sv
Publication of SE436645B publication Critical patent/SE436645B/sv
Publication of SE436645C publication Critical patent/SE436645C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7604972A 1976-04-29 1976-04-29 Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar SE436645C (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE7604972A SE436645C (sv) 1976-04-29 1976-04-29 Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
DE19772717741 DE2717741A1 (de) 1976-04-29 1977-04-21 Synthetisches antigen-wirksames polypeptid
US05/789,665 US4107298A (en) 1976-04-29 1977-04-21 Antigenically active polypeptide and a process for its preparation
GB17167/77A GB1570375A (en) 1976-04-29 1977-04-25 Synthetic antigenically active polypeptide and a process for its preparation
JP4977077A JPS52156819A (en) 1976-04-29 1977-04-28 Synthetic polypeptide active as antigen
CA277,237A CA1106360A (en) 1976-04-29 1977-04-28 Antigenically active polypeptide and a process for its preparation
MX775685U MX4699E (es) 1976-04-29 1977-04-28 Procedimiento para la preparacion de un polipeptido antigenicamente activo
DD7700198643A DD130476A5 (de) 1976-04-29 1977-04-28 Synthetisches antigen-wirksames polypeptid
BR7702737A BR7702737A (pt) 1976-04-29 1977-04-29 Processo para determinar a presenca de capa em diferentes estagios do desenvolvimento do cancer
FR7713001A FR2349569A1 (fr) 1976-04-29 1977-04-29 Polypeptide synthetique ayant une activite antigenique et sa preparation
CH539877A CH630060A5 (de) 1976-04-29 1977-04-29 Verfahren zur herstellung eines antigen-wirksamen polypeptides.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7604972A SE436645C (sv) 1976-04-29 1976-04-29 Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar

Publications (3)

Publication Number Publication Date
SE7604972L SE7604972L (sv) 1977-10-30
SE436645B SE436645B (sv) 1985-01-14
SE436645C true SE436645C (sv) 1996-07-22

Family

ID=20327727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7604972A SE436645C (sv) 1976-04-29 1976-04-29 Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar

Country Status (11)

Country Link
US (1) US4107298A (sv)
JP (1) JPS52156819A (sv)
BR (1) BR7702737A (sv)
CA (1) CA1106360A (sv)
CH (1) CH630060A5 (sv)
DD (1) DD130476A5 (sv)
DE (1) DE2717741A1 (sv)
FR (1) FR2349569A1 (sv)
GB (1) GB1570375A (sv)
MX (1) MX4699E (sv)
SE (1) SE436645C (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
DE3109696A1 (de) * 1981-03-13 1982-09-30 Gerhard Dr. med. 7800 Freiburg Hunsmann Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff
ZA831547B (en) * 1982-03-15 1984-10-31 New York Blood Center Inc Fatty acid carriers for synthetic vaccines
US4708871A (en) * 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
DE3741726A1 (de) * 1987-12-09 1989-06-22 Ruhrchemie Ag Verfahren zur herstellung von tertiaeren n,n-dimethylaminen
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
JPH03504501A (ja) * 1988-05-27 1991-10-03 マゲイニン　サイエンセス　インコーポレーテッド 両親媒性ペプチドとその用途
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
JPH07500342A (ja) * 1991-10-16 1995-01-12 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 生物学的活性ペプチドおよび抗生物質を有する組成物およびこれを用いた治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA728129A (en) * 1966-02-15 Kappeler Heinrich Process for the manufacture of a polypeptide
CA787918A (en) * 1968-06-18 Schwyzer Robert Process for the manufacture of a polypeptide
US3715190A (en) * 1971-09-23 1973-02-06 Univ Sherbrooke System for the solid-phase peptide synthesis
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US3929756A (en) * 1973-11-21 1975-12-30 Univ Brandeis Synthetically produced tridecapeptide having the same activity as the hypothalamic substance, neurotensin
JPS5116667A (sv) * 1974-07-30 1976-02-10 Shionogi Seiyaku Kk

Also Published As

Publication number Publication date
MX4699E (es) 1982-08-04
FR2349569A1 (fr) 1977-11-25
CA1106360A (en) 1981-08-04
FR2349569B1 (sv) 1980-10-24
BR7702737A (pt) 1978-03-21
GB1570375A (en) 1980-07-02
DD130476A5 (de) 1978-04-05
SE7604972L (sv) 1977-10-30
SE436645B (sv) 1985-01-14
US4107298A (en) 1978-08-15
DE2717741A1 (de) 1977-11-17
CH630060A5 (de) 1982-05-28
JPH0236906B2 (sv) 1990-08-21
JPS52156819A (en) 1977-12-27
DE2717741C2 (sv) 1990-10-25

Similar Documents

Publication Publication Date Title
SE436645C (sv) Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
NL192603B (nl) Cosmetisch product en werkwijze ter bereiding daarvan.
NL7503754A (nl) Werkwijze voor de bereiding van anilidederiva- ten, alsmede met toepassing hiervan bereide microbicide preparaten.
SE442013B (sv) Cykliska sulfonyloxiimider for anvendning vid framstellning av cykliska aminosyror
NL7511598A (nl) Voorgaren en werkwijze voor het vervaardigen ervan.
NO143888C (no) Kosmetisk middel for glatting av huden.
NL148930B (nl) Werkwijze voor de bereiding van mengsels met nematische eigenschappen alsmede voor de bereiding van daarvoor geschikte nieuwe 4-((4'-alkylbenzylideen)-amino)-benzonitrilen.
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NL7704724A (nl) Tumor-antigeen en zijn bereiding.
SE7708621L (sv) 2-bensyl-pyrrolidiner, sett for framstellning derav och anvendning derav som lekemedel
NL7706622A (nl) Polyenen en werkwijze voor hun bereiding.
NL7703880A (nl) Hondsdolheidsvaccin en zijn bereiding.
NO146659C (no) Kosmetiske preparater for pleie av huden.
IT1055580B (it) Ossimetelen 2 6 morfo lino 4 3a benzimidazoli loroprocedimento di preparazione e loro applicazione in terapeutica
NL7513941A (nl) Derivaten en tetanustoxinen, hun bereiding en geneesmiddelen met daarin deze derivaten.
SE7507238L (sv) Sampolymerisat, och forfarande for deras framstellning och anvendning.
TR18255A (tr) N-silfenillenmis 2,3-dihidrobenzofuranil-7-metil karbamatlar bunlarin hazirlanmasina mahsus usuller ve bunlarin ensekstisidler olarak kullanilmalari
NL7700203A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten, alsmede aldus verkregen gevormde pre- paraten.
NL7514765A (nl) Tyrosine derivaten en werkwijze voor hun bereiding en toepassing.
NL7708069A (nl) Peptidederivaten en de bereiding daarvan.
IT1115363B (it) Amminoalcossibenzofurani,loro procedimento di preparazione e loro applicazione in terapia
IT1051609B (it) Originali isopropil 2 tetraidro ossazine 1.3 sostituite,loro procedimento di preparazione e loro applicazione in terapia
SE7510082L (sv) Polypeptid samt forfarande for framstellning av densamma
NL7710325A (nl) Werkwijze ter bereiding van nieuwe chinolinede- rivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
SE409035B (sv) Analogiforfarande for framstellning av n-(faryl-och tienylmetyl)-7alfa-6,14-endoeteno-tetrahydronororipaviner och tebainer